Every stage of cancer metastasis, immune surveillance evasion, and therapeutic resistance
is influenced by tumor microenvironment (TME). In light of this, nanomedicines design based …

Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …

Advancements in micro‐resolution 3D printers have significantly facilitated the development
of highly complex mass‐producible drug delivery platforms. Conventionally, due to the …

To develop a next-generation anticancer metal-based drug, realize the multi-targeted
combination therapy of protein drug and metal-based drug for cancer, solve their co-delivery …

Tumor vaccine that can effectively activate or strengthen the body's antitumor immune
response to kill and eliminate tumor cells has attracted widespread attention. Currently …

Although immunotherapies have made progress in cancer treatment, their clinical response
rates vary widely and are typically low due to sparse immune cell infiltration (immune “cold”) …

Autoimmune diseases and malignant tumors are the two hotspots and difficulties that are
currently being studied and concerned by the medical field. The use of PD-1/PD-L1 …

In situ vaccination is a desirable strategy for cancer immunotherapy due to its convenience
and capacity to target tumor antigens. Here, an in situ nanovaccine based on a cationic …

Lung cancer is one of the malignant tumors that has seen the most rapid growth in terms of
morbidity and mortality in recent years, posing the biggest threat to people's health and lives …

With the focus in the field of cancer nanomedicine shifting from direct tumor targeting to
modulation of the immune system, new opportunities arise for the employment of …